AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 283: H1099-H1107, 2002. First published May 23, 2002; doi:10.1152/ajpheart.00270.2002
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/3/H1099    most recent
00270.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reffelmann, T.
Right arrow Articles by Kloner, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reffelmann, T.
Right arrow Articles by Kloner, R. A.
Vol. 283, Issue 3, H1099-H1107, September 2002

Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit

Thorsten Reffelmann and Robert A. Kloner

The Heart Institute, Good Samaritan Hospital, University of Southern California, Los Angeles, California 90017-2395

The aim was to define the degree and time course of reperfusion-related expansion of no reflow. In five groups of anesthetized, open-chest rabbits (30-min coronary occlusion and different durations of reperfusion), anatomic no reflow was determined by injection of thioflavin S at the end of reperfusion and compared with regional myocardial blood flow (RMBF; radioactive microspheres) and infarct size (triphenyltetrazolium). The area of no reflow progressively increased from 12.2 ± 4.2% of the risk area after 2 min of reperfusion to 30.8 ± 3.1% after 2 h and 34.9 ± 3.3% after 8 h and significantly correlated with infarct size after 1 h of reperfusion (r = 0.88-0.97). This rapid expansion of no reflow predominantly occurred during the first 2 h, finally encompassing ~80% of the infarct size, and was accompanied by a decrease of RMBF within the risk area, being hyperemic after 2 min of reperfusion (3.78 ± 0.75 ml · min-1 · g-1) and plateauing at a level of ~0.9 ml · min-1 · g-1 by 2 and 8 h of reperfusion (preischemic RMBF: 2.06 ± 0.01 ml · min-1 · g-1). The development of macroscopic hemorrhage lagged behind no reflow, was closely correlated with it, and may be the consequence of microvascular damage.

myocardial infarction; microcirculation; vasculature; hemorrhage


This article has been cited by other articles:


Home page
Br J AnaesthHome page
C. Rempf, T. Standl, K. Schenke, K. Chammas, A. Gottschalk, M.-A. Burmeister, and A. Gottschalk
Administration of bovine polymerized haemoglobin before and during coronary occlusion reduces infarct size in rabbits
Br. J. Anaesth., October 1, 2009; 103(4): 496 - 504.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Y. Mikami, H. Sakuma, M. Nagata, M. Ishida, T. Kurita, I. Komuro, and M. Ito
Relation Between Signal Intensity on T2-Weighted MR Images and Presence of Microvascular Obstruction in Patients With Acute Myocardial Infarction
Am. J. Roentgenol., October 1, 2009; 193(4): W321 - W326.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. E. Rochitte
Microvascular obstruction the final frontier for a complete myocardial reperfusion.
J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2239 - 2240.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. Hale, A. Mehra, J. Leeka, and R. A. Kloner
Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H421 - H425.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. G. Leshnower, H. Sakamoto, H. Hamamoto, A. Zeeshan, J. H. Gorman III, and R. C. Gorman
Progression of myocardial injury during coronary occlusion in the collateral-deficient heart: a non-wavefront phenomenon
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1799 - H1804.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. J. van den Bos, T. Baks, A. D. Moelker, W. Kerver, R.-J. van Geuns, W. J. van der Giessen, D. J. Duncker, and P. A. Wielopolski
Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking?
Eur. Heart J., July 1, 2006; 27(13): 1620 - 1626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. J. Wacker, S. R. Best, L. M. Kosloski, C. J. Stachura, R. L. Smoot, C. B. Porter, and J. A. Orr
Thromboxane A2-induced arrhythmias in the anesthetized rabbit
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1353 - H1361.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. A. Burmeister, C. Rempf, T. G. Standl, S. Rehberg, S. Bartsch-Zwemke, T. Krause, S. Tuszynski, A. Gottschalk, and J. Schulte am Esch
Effects of prophylactic or therapeutic application of bovine haemoglobin HBOC-200 on ischaemia-reperfusion injury following acute coronary ligature in rats
Br. J. Anaesth., December 1, 2005; 95(6): 737 - 745.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Tan, Z. Ma, L. Han, R. Du, L. Zhao, X. Wei, D. Hou, B. H. Johnstone, M. R. Farlow, and Y. Du
Caffeic acid phenethyl ester possesses potent cardioprotective effects in a rabbit model of acute myocardial ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2265 - H2271.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
T. Reffemann and R. A. Kloner
Microvascular Alterations After Temporary Coronary Artery Occlusion: The No-Reflow Phenomenon
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 163 - 172.
[Abstract] [PDF]


Home page
HeartHome page
E Falk and L Thuesen
Pathology of coronary microembolisation and no reflow
Heart, September 1, 2003; 89(9): 983 - 985.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Reffelmann and R. A. Kloner
Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage?
Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1134 - H1141.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online